Sort   by:  
 Page size 
UnknownAbsolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.
Not available
S-EPMC3530689 | biostudies-literature
TranscriptomicsRNA-seq profiling of MED patient-derived (MATN3 V194D) and unaffected iPSC-chondrogenesis
PBMCs from MED patients carrying the MATN3 V194D mutation and unaffected controls were reprogrammed into hiPSCs. Samples were differentiated into Day 21 cartilage pellets via an iMSC intermediate.
ORGANISM(S): Homo sapiens 
2026-02-12 | E-MTAB-16600 | biostudies-arrayexpress
TranscriptomicsTranscriptomic time-series of human embryonic stem cell differentiation to hypertrophic-like chondrocytes via a mesenchymal intermediate
This study characterizes the gene expression changes during the differentiation of the human embryonic stem cell (hESC) line Man13 into hypertrophic-like cartilage pellets. Samples include five key stages: pluripotent cells (TeSR™-E8™), induced mesenchymal stromal cells (iMSCs), and three-dimensiona...
ORGANISM(S): Homo sapiens 
2026-02-12 | E-MTAB-16597 | biostudies-arrayexpress
TranscriptomicsRNA-seq profiling of MED patient-derived (MATN3 T195K) and unaffected iPSC-chondrogenesis
PBMCs from MED patients carrying the MATN3 T195K mutation and unaffected controls were reprogrammed into hiPSCs using Sendai virus. Data includes three differentiation stages: pluripotent hiPSCs, iMSCs, and Day 21 cartilage pellets. Sequencing was performed at the University Genomics Core Facility.
ORGANISM(S): Homo sapiens 
2026-02-12 | E-MTAB-16598 | biostudies-arrayexpress
TranscriptomicsGene expression profile of control and CRISPR-edited MATN3 V194D mutant Day 21 cartilage pellets differentiated from the human ESC line MAN13
RNA-seq of control and MATN3 V194D mutant cartilage pellets. The MATN3 V194D mutation was introduced using CRISPR-Cas9 in pluripotent cells before differentiation through an iMSC intermediate to Day 21 cartilage pellets.
ORGANISM(S): Homo sapiens 
2026-02-12 | E-MTAB-16599 | biostudies-arrayexpress
GenomicsEGAD00000000056
WTCCC project samples from the primary biliary cirrhosis cohort
EGAD00000000056 | EGA
GenomicsWTCCC3 case-control study for Primary Biliary Cirrhosis
Genome-wide association scan was performed in 1,840 cases of primary biliary cirrhosis and 5,163 controls. Replication of new associations was tested in an independent set of 620 cases and 2,514 controls.
EGAS00000000039 | EGA
UnknownClinical impact of genomic testing in patients with suspected monogenic kidney disease.
Not available
S-EPMC7790755 | biostudies-literature
TranscriptomicsTranscriptional profiling of primary human alveolar macrophages challenged with Streptococcus pneumoniae from patients with chronic obstructive pulmonary disease compared to healthy donors
Transcriptional profiling of primary human alveolar macrophages (AMs) comparing control untreated AMs with AMs exposed with Serotype 14 Streptococcus pneumoniae (NCTC11902) strain (MOI 10) for 4 hours) Two-condition experiment, control AMs vs. infected AMs. Biological replicates: 3 control replicat...
ORGANISM(S): Homo sapiens 
2018-02-26 | E-MTAB-6491 | biostudies-arrayexpress
UnknownCommon variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC2893806 | biostudies-literature
Sort   by:  
 Page size